Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/physique/applications-of-targeted-nano-drugs-and-delivery-systems/descriptif_3785403
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=3785403

Applications of Targeted Nano Drugs and Delivery Systems Nanoscience and Nanotechnology in Drug Delivery Micro and Nano Technologies Series

Langue : Anglais

Coordonnateurs : Mohapatra Shyam, Ranjan Shivendu, Dasgupta Nandita, Thomas Sabu, Mishra Raghvendra Kumar

Couverture de l’ouvrage Applications of Targeted Nano Drugs and Delivery Systems

Applications of Targeted Nano-Drugs and Delivery Systems: Nanoscience and Nanotechnology in Drug Delivery explores the applications of Nano-drugs and their delivery systems, investigating the role they can play in key body systems and major diseases. The book explores how nanotechnology can be deployed in developing new drug delivery systems and how they enable pharmaceutical companies to reformulate existing drugs on the market, thereby extending the lifetime of products and enhancing performance by increasing effectiveness, safety and patient adherence, and ultimately reducing healthcare cost. Reflecting the interdisciplinary nature of the subject matter, this book includes contributions by experts from different fields.

Readers will find a reference and practical source of guidance for researchers, students and scientists working in the fields of nanotechnology, materials science, and technology and biomedical science.

1. Nanotherapeutics and Nanobiotechnology2. Application and Perspective of pH-Responsive Nano Drug Delivery Systems3. Mechanism for Development of Nanobased Drug Delivery System4. Nanobased Nano Drug Delivery: A Comprehensive Review5. Recent Advances in Development of Nano Drug Delivery6. Thermoresponsive Drug Delivery Systems, Characterization and Application7. Graphene and Graphene-Based Nanomaterials Are Suitable Vehicles for Drug Delivery8. Combination Strategies for Targeted Delivery of Nanoparticles for Cancer Therapy9. Nanotechnology Toward Treating Cancer: A Comprehensive Review10. Nanoparticles as Delivery Systems in Cancer Therapy: Focus on Gold Nanoparticles and Drugs11. Trends in Nanotechnology for Practical Applications12. Antiviral and Antimicrobial (Antibacterial) Potentiality of Nano Drugs13. Antiviral and Antimicrobial Potentiality of Nano Drugs14. Nanotechnology in Targeted Drug Delivery and Therapeutics15. Engineering Nanomaterials for Smart Drug Release: Recent Advances and Challenges16. Nano Drugs for Curing Malaria: The Plausibility17. Nanoparticles Mediated Gene Knockout Through miRNA Replacement: Recent Progress and Challenges18. Transdermal and Intravenous Nano Drug Delivery Systems: Present and Future19. Nanobased Intravenous and Transdermal Drug Delivery Systems20. Electrospun Nanofibers for Drug Delivery in Regenerative Medicine
Shyam Mohapatra is Distinguished USF Health Professor, Director of the Division of Translational Medicine at the University of South Florida. He also directs the USF Center for Research and Education in Nanobioengineering and is a Research Career Scientist at the James A. Haley VA Hospital in Tampa. He also serves as Associate Dean of Graduate Programs at the USF College of Pharmacy, and established a highly innovative Master of Science program in Pharmaceutical Nanotechnology. He has published over 170 papers and holds over 30 U.S. and international patents. He is a Fellow of the AAAAI, NAI, and AIMBE, and a 2014 inductee of the Florida Inventors Hall of Fame.
Dr. Shivendu Ranjan has extensive expertise in Micro/Nanotechnology and is currently working as Head R&D and Technology Development at E-Spin Nanotech Pvt. Ltd. He has founded and drafted the concept for the first edition of the “VIT Bio Summit” in 2012, and the same has been continued till date by the university. He has worked in CSIR-CFTRI, Mysuru, India as well as UP Drugs and Pharmaceutical Co. Ltd., India and IIFPT, Thanjavur, MoFPI, Govt of India. At IIFPT, Thanjavur, he was involved in a project funded by a leading pharmaceutical company, Dr. Reddy’s Laboratories and have successfully engineered micro-vehicles for model drug molecules.
His research interests are multidisciplinary and include: Micro/Nanobiotechnology, Nano-toxicology, Environmental Nanotechnology, Nanomedicine, and Nanoemulsions. . He is the associate editor of Environmental Chemistry Letters – a Springer journal of 3.59 impact factor – and an editorial board member in Biotechnology and Biotechnological Equipment(Taylor and Francis). He is serving as executive editor of a journal in iMed Press, USA, and also serving as editorial board member and referee for reputed international peer-reviewed journals. He is the author of many books and edited six books.
Dr. Nandita Dasgupta has vast working experience in Micro/Nanoscience and
  • Enables readers from different fields to access recent research and protocols across traditional boundaries
  • Focuses on protocols and techniques, as well as the knowledge base of the field, thus enabling those in R&D to learn about, and successfully deploy, cutting-edge techniques
  • Explores the applications of Nano-drugs and their delivery systems, investigating the role they can play in key body systems and major disease types

Date de parution :

Ouvrage de 682 p.

19x23.3 cm

Disponible chez l'éditeur (délai d'approvisionnement : 14 jours).

215,20 €

Ajouter au panier

Thèmes d’Applications of Targeted Nano Drugs and Delivery Systems :

Mots-clés :

Active targeting; Albumin-bound nanoparticles; Antibacterial; Anticancer drug delivery; Antimicrobial resistance; Antimicrobial; Antiviral; Bacteria; Biocompatibility; Biodispersibility; Biofilm; Biologics; Biosimilar; Blood�brain barrier; Cancer nanomedicines; Cancer; Carbon nanostructures; Carbon nanotubes; Central nervous system; Ceramides NPs; Clinical translations; Conjugation strategies; Critical solution temperature; Delivery systems; Dendrimer; Dendrimers; Drug carrier; Drug delivery system; Drug delivery systems; Drug delivery; Drug targeting; Elastin-like peptides; Electrospinning; Fabrication; FDA; FDA-approved products and in clinical development; Fibers; Fullerene; Functionalization of graphene; Fungi; Gene delivery; Gene expression; Gene therapy; Glass transition temperature; Gold nanoparticles; Gram positive; Gram-negative; Graphene oxide; Graphene; Growth factor; Intravenous delivery; Intravenous; Iontophoresis; Knockouts; Leishmaniasis; Lipid nanoparticles; Lipids; Liposomes; Malaria; Marketed formulations; Micelles; miRNA; Nano drug delivery systems; Nano drug; Nano drugs; Nanobased drug delivery; Nanobiotechnology; Nanocarrier; Nanocarriers; Nanoformulation; Nanogels; Nanomaterials; Nanomedicine; Nanomedicines; Nanoparticles; Nanotechnology; Niosome; Passive targeting; Patents; pH sensitive; Photodynamic therapy; Polymer nanoparticles; Polymer; Polymeric micelle; Polymers; Proteins; Radiotherapy; Reduced graphene oxide; Regenerative tissue engineering; RNA interference; Routes of administration; Sensitization; Smart; Sonodynamic therapy; Stimuli-responsive; Stimuli-sensitive release; Target site; Targeted delivery; Targeted drug delivery; Targeted nano drugs; Targeting; Thermoresponsive polymers; Toxicity; Transdermal drug delivery; Transdermal; Ultrasound; Virus